The 2027 Medicare cut is a commercial rate cut in disguise

By

Dilpreet Sahota, Founder and CEO, Trek Health

•

September 16, 2026

The 2027 Medicare cut is a commercial rate cut in disguise

CMS's proposed CY2027 conversion factor cut looks like a Medicare story. Because most commercial contracts are still written as a percentage of Medicare, it isn't. Here's the math.

What CMS actually proposed

On July 14, 2026, CMS released the CY2027 Medicare Physician Fee Schedule proposed rule. Two numbers matter for anyone modeling revenue:

Comment period closed September 14, 2026. The final rule is expected around November 1, effective January 1.

Why this is a commercial rate story, not a Medicare story

Most commercial contracts are still written as a percentage of Medicare, so the Medicare Physician Fee Schedule quietly sets the ceiling for private pay. When the conversion factor moves, the base rate moves for every code on every commercial contract indexed to it, automatically, unless a contract has a floor, a base-year lock, or an explicit renegotiation clause.

Milliman puts 2025 commercial reimbursement at roughly 196% of fully loaded Medicare on average across medical services. That's the ratio that gets applied on top of the conversion factor. Cut the factor 1.68% and the whole stack scales down with it.

Simple version: if a commercial payer pays you "150% of Medicare" for a code, and Medicare's base rate for that code falls 1.68% on January 1, your commercial rate for that code falls 1.68% too. Nobody at that payer will call you to negotiate it.

What this looks like on a real book

Take a mid-sized multispecialty group booking $180M in commercial physician revenue. Assume 68% of that revenue runs through contracts indexed to Medicare, and roughly 12% of revenue comes from same-day E/M billed alongside procedures. Apply the CY2027 proposal at non-APM rates and the E/M reduction on top:

Worked example: applying the CY2027 proposal to a $180M multispecialty commercial book yields an estimated -$3.5M annualized impact (-1.96% of commercial revenue), split between -$2.06M conversion factor pass-through and -$1.47M same-day E/M reduction.

Two numbers stand out. First, the conversion factor pass-through is the larger of the two effects, worth about -$2.1M a year on this book. It hits every commercial contract indexed to Medicare, on every code, without a renegotiation. Second, the same-day E/M reduction adds another -$1.5M, concentrated on procedural service lines. On a $500M book, roughly double both numbers.

Why most providers will miss it

Three structural reasons:

Three questions every RCM director should answer by November 1

What we're recommending our customers do

Between now and October 31: build a one-page position statement for each of your top five payers, containing (a) current effective rates on the top 20 codes by revenue, (b) peer benchmarks from the latest MRF snapshot, (c) the 2027 pass-through delta at proposed rule levels, and (d) the specific redlines you want in your next renewal.

Providers who walk into a fall renegotiation with that document reset the starting point. Providers who don't will find out in Q1 close what the industry-wide silent cut cost them.

Free through October: Trek will pull your effective rates from the latest MRFs, benchmark them against peers, layer the CY2027 proposal on top, and hand back a one-page position statement per payer. Turnaround: 5 business days. Request your rate check.